Elutia to Participate in Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Elutia (Nasdaq: ELUT), a pioneer in drug-eluting biomatrix technologies, has announced its participation in two upcoming investor conferences in April 2025.
The company's leadership team, including Dr. Randy Mills (President and CEO) and Matt Ferguson (CFO), will attend:
- The LD Micro 15th Annual Invitational in New York on April 10, 2025, presenting at 12:30 p.m. ET
- The Planet Microcap Showcase in Las Vegas on April 23, 2025, presenting at 4:00 p.m. ET
Both events will feature company presentations and one-on-one meetings with investors. Institutional investors can schedule meetings through conference representatives or by contacting IR@elutia.com.
Details
News Market Reaction – ELUT
The recorded move for ELUT in the trading session of this news was +5.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SILVER SPRING, Md., April 03, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences:
LD Micro 15th Annual Invitational – New York, NY
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Thursday, April 10, 2025, 12:30 p.m. ET (9:30 a.m. PT)
Webcast: Click Here
Planet Microcap Showcase – Las Vegas, NV
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Wednesday, April 23, 2025, 4:00 p.m. ET (1:00 p.m. PT)
Webcast: Click Here
Elutia management will also participate in 1x1 investor meetings. Institutional investors interested in scheduling a meeting may contact an LD Micro or Planet Microcap representative or email IR@elutia.com.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.